2-(4-Fluorophenyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 250mg

IXABEPILONE, 95%, 10mg

2-(((1R,3r,5S)-8-azabicyclo[3.2.1]octan-3-yl)oxy)thiazole dihydrochloride, 95.0%, 250mg

Bis(2-ethylhexyl) cyclohexane-1,2-dicarboxylate, 97.0%, 100g

DIBUTAN-2-YL BUTANEDIOATE, 95.0%, 5g

2-Amino-5-methyl-4,5,6,7-tetrahydrothiazolo[4,5-c]pyridine, 95.0%, 250mg

dimethyl sulfoxide D6 with TMS (0.03 vol%), 99.8 at%D, 7.5 ml, glass packaging amp.

Legionella GVPC Supplement

Microliter syringe MICROLITER® series 7000 Point type 2, 1.0 µl, 7001 KH, 1 piece

Flat flange reaction vessel, cylindrical, graduated, with tempering and vacuum jacket and drain valve, DN 150, 500 ml, 120 mm, 1 Piece

5-Bromo-N-(furan-2-ylmethyl)pyrimidin-2-amine, 95.0%, 5g

5-(Aminomethyl)-2-methylphenol hydrochloride, 1g

2-Chloro-N-(4-methoxybenzyl)aniline, 98%, 5g